Xeris Biopharma Holdings financial statements

제리스 바이오파머NASDAQ:XERS · Nasdaq · Healthcare · sector #17
$10.07-0.59%
2026-10-06 close

Xeris Biopharma Holdings's published financial data is dated 2026-10-04. 2024 revenue was $203M. 2024 operating profit was −$36M.

Reported results

Xeris Biopharma Holdings notifications

Quantus Signal · live data · not investment advice · Privacy Policy